Checkpoint inhibitor immune-related adverse events: A focused review on autoantibodies and B cells as biomarkers, advancements and future possibilities

J Taylor, A Gandhi, E Gray, P Zaenker - Frontiers in immunology, 2023 - frontiersin.org
The use of immune checkpoint inhibitors (ICIs) has evolved rapidly with unprecedented
treatment benefits being obtained for cancer patients, including improved patient survival …

Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?

C Hieber, S Grabbe, M Bros - Biomolecules, 2023 - mdpi.com
Aging attenuates the overall responsiveness of the immune system to eradicate pathogens.
The increased production of pro-inflammatory cytokines by innate immune cells under basal …

[HTML][HTML] Unraveling the tumor microenvironment: insights into cancer metastasis and therapeutic strategies

M El-Tanani, SA Rabbani, R Babiker, I Rangraze… - Cancer Letters, 2024 - Elsevier
This comprehensive review delves into the pivotal role of the tumor microenvironment (TME)
in cancer metastasis and therapeutic response, offering fresh insights into the intricate …

T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems

Y Yang, F Yang, Z Huang, Y Li, H Shi, Q Sun… - Frontiers in …, 2023 - frontiersin.org
The immune system provides full protection for the body by specifically identifying 'self'and
removing 'others'; thus protecting the body from diseases. The immune system includes …

[HTML][HTML] Emerging treatment approaches for triple-negative breast cancer

M Capuozzo, V Celotto, M Santorsola, A Fabozzi… - Medical Oncology, 2023 - Springer
Approximately, 15% of global breast cancer cases are diagnosed as triple-negative breast
cancer (TNBC), identified as the most aggressive subtype due to the simultaneous absence …

[HTML][HTML] Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer

S Liu, Z Wang, L Hu, C Ye, X Zhang, Z Zhu, J Li… - Translational …, 2024 - Elsevier
Immune checkpoints inhibitors are effective but it needs more precise biomarkers for patient
selection. We explored the biological significance of LINC00862 in pan-cancer by …

[HTML][HTML] Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibition

B Alharbi, H Qanash, NK Binsaleh, S Alharthi… - Scientific Reports, 2023 - nature.com
Immunotherapies, including immune checkpoint inhibitors, have limitations in their effective
treatment of malignancies. The immunosuppressive environment associated with the tumor …

A case report and literature review on reactive cutaneous capillary endothelial proliferation induced by camrelizumab in a nasopharyngeal carcinoma patient

Y Lin, Y Lin, X Zhong, Q Chen, S Tang… - Frontiers in Oncology, 2023 - frontiersin.org
Camrelizumab, a monoclonal antibody, blocks programmed cell death protein-1 from
binding to T cells and programmed cell death ligand 1 on tumor cells, thereby ensuring …

Cyclooxygenase-2 blockade is crucial to restore natural killer cell activity before anti-CTLA-4 therapy against high-grade serous ovarian cancer

F Gómez-Valenzuela, I Wichmann, F Suárez, S Kato… - Cancers, 2023 - mdpi.com
Simple Summary Cyclooxygenase-2 (COX-2) expression causes several changes in the
tumor microenvironment (TME) of ovarian cancer, which are associated with a low …

Liver cell type-specific targeting by nanoformulations for therapeutic applications

L Kaps, MJ Limeres, P Schneider, M Svensson… - International Journal of …, 2023 - mdpi.com
Hepatocytes exert pivotal roles in metabolism, protein synthesis and detoxification. Non-
parenchymal liver cells (NPCs), largely comprising macrophages, dendritic cells, hepatic …